Historique de carrière de Shannon Inman
Anciens postes connus de Shannon Inman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENPREX, INC. | Directeur Technique/Scientifique/R&D | 21/04/2020 | 01/11/2021 |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Shannon Inman
| Texas A&M University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENPREX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Shannon Inman
- Expérience
